{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:18:09Z","timestamp":1765826289011,"version":"3.48.0"},"reference-count":27,"publisher":"BMJ","issue":"6","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,5,9]]},"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The introduction of targeted therapies for cancer has contributed to dramatic improvements in patient survival. Nevertheless, several targeted therapies have been associated with \u2018off-target\u2019 adverse effects, based on varying levels of evidence. To date, this evidence has not been systematically synthesised. We will synthesise published systematic review evidence of cardiovascular toxicity associated with targeted cancer therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We will include systematic reviews of randomised controlled trials and observational studies that report on cardiovascular outcomes for individual agents. We will identify systematic reviews by applying predeveloped, standardised search strategies within Embase, Medline and Cochrane Central. Two independent reviewers will identify reviews published up to 31 December 2016 using predefined eligibility criteria. They will resolve ambiguous cases through consensus, arbitrated by a third reviewer if required. The reviewers will extract and report data according to methodological guidelines for overviews provided by the Cochrane Collaboration, Joanna Briggs Institute and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols. They will assess the quality of included reviews by applying the Assessment of Multiple Systematic Reviews tool. They will judge the quality of evidence in included reviews based on their assessment of bias and incorporation into the interpretation of findings. In synthesising the evidence, we will classify agents based on systematic review evidence of toxicity (sufficient, probable, possible or indeterminate) for specific cardiovascular outcomes (congestive heart failure, myocardial infarction, ischaemic heart disease, left ventricular ejection fraction decline, cerebrovascular disease, pulmonary embolism, thrombosis and hypertension). This will provide clinicians and patients with an accessible synthesis based on robust methodology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethics approval is not required for overviews. We will conduct the study in collaboration with consumer representatives. We will submit results for peer-review publication, and disseminate them through established clinical and consumer networks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42017080014.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-021064","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T02:10:22Z","timestamp":1678846222000},"page":"e021064","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiovascular toxicity of targeted therapies for cancer: a protocol for an overview of systematic reviews"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1570-2852","authenticated-orcid":false,"given":"Marina T","family":"van Leeuwen","sequence":"first","affiliation":[{"name":"Centre for Big Data Research in Health, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Luu","sequence":"additional","affiliation":[{"name":"Centre for Big Data Research in Health, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Gurney","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Science, Macquarie University, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin R","family":"Brown","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Science, Macquarie University, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Webber","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Prince of Wales Hospital and Royal Hospital for Women, Randwick, New South Wales, Australia"},{"name":"Prince of Wales Clinical School, University of New South Wales, UNSW, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sallie-Anne","family":"Pearson","sequence":"additional","affiliation":[{"name":"Centre for Big Data Research in Health, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Hunt","sequence":"additional","affiliation":[{"name":"Cancer Voices NSW, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3612-8298","authenticated-orcid":false,"given":"Claire M","family":"Vajdic","sequence":"additional","affiliation":[{"name":"Centre for Big Data Research in Health, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,6,27]]},"reference":[{"key":"2025121511151943000_8.6.e021064.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.65"},{"key":"2025121511151943000_8.6.e021064.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018347"},{"key":"2025121511151943000_8.6.e021064.3","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJMra1100265","article-title":"Cardiovascular toxic effects of targeted cancer therapies","volume":"375","author":"Moslehi","year":"2016","journal-title":"N Engl J Med"},{"key":"2025121511151943000_8.6.e021064.4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/14779072.2015.1027686","article-title":"Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity","volume":"13","author":"O\u2019Hare","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2025121511151943000_8.6.e021064.5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002843","article-title":"Cancer therapy-related cardiac dysfunction and heart failure: part 2: prevention, treatment, guidelines, and future directions","volume":"9","author":"Hamo","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2025121511151943000_8.6.e021064.6","unstructured":"Becker LA , Oxman AD . Chapter 22: Overviews of reviews. In: Higgins J , Green S , eds. Cochrane Handbook for Systematic Reviews of Interventions Version 510: The Cochrane Collaboration, 2011."},{"key":"2025121511151943000_8.6.e021064.7","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2017-097621"},{"key":"2025121511151943000_8.6.e021064.8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","article-title":"Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach","volume":"13","author":"Aromataris","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"2025121511151943000_8.6.e021064.9","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"2025121511151943000_8.6.e021064.10","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-1-2"},{"key":"2025121511151943000_8.6.e021064.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60903-8"},{"key":"2025121511151943000_8.6.e021064.12","unstructured":"World Health Organisation (WHO). Collaborating Centre for Drug Statistics and Methodology. Guidelines for ATC classification and DDD assignment, 2017 Oslo, Norway. 2016 https:\/\/www.whocc.no\/filearchive\/publications\/2017_guidelines_web.pdf (accessed 12 Sep 2017)."},{"key":"2025121511151943000_8.6.e021064.13","unstructured":"World Health Organization (WHO). International Statistical Classification of Diseases and Related Health Problems, 10th Revision (online). Geneva: World Health Organization, 2016."},{"key":"2025121511151943000_8.6.e021064.14","unstructured":"BMJ Evidence Centre. BMJ clinical evidence: systematic review search filter resource. http:\/\/clinicalevidence.bmj.com\/x\/set\/static\/ebm\/learn\/665076.html?locale=en_AU (accessed 12 Sep 2017)."},{"key":"2025121511151943000_8.6.e021064.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"2025121511151943000_8.6.e021064.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2008.10.009"},{"key":"2025121511151943000_8.6.e021064.17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-7-10"},{"key":"2025121511151943000_8.6.e021064.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.06.015"},{"key":"2025121511151943000_8.6.e021064.19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jrsm.1229","article-title":"Risk of bias in overviews of reviews: a scoping review of methodological guidance and four-item checklist","volume":"8","author":"Ballard","year":"2017","journal-title":"Res Synth Methods"},{"key":"2025121511151943000_8.6.e021064.20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13643-017-0534-3","article-title":"Selecting and implementing overview methods: implications from five exemplar overviews","volume":"6","author":"Pollock","year":"2017","journal-title":"Syst Rev"},{"key":"2025121511151943000_8.6.e021064.21","unstructured":"Cochrane Comparing Multiple Interventions Methods Group (CMIMG). Review type and methodological considerations- background paper for the first part of the Paris CMIMG Discussion. 2012 http:\/\/methods.cochrane.org\/sites\/methods.cochrane.org.cmi\/files\/public\/uploads\/Review%20type%20and%20methods%20for%20comparing%20multiple%20interventions_12APR12.pdf (accessed 17 October 2017)."},{"key":"2025121511151943000_8.6.e021064.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.12.008"},{"key":"2025121511151943000_8.6.e021064.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70267-4"},{"key":"2025121511151943000_8.6.e021064.24","unstructured":"Howick J , Chalmers I , Glasziou P , et al . The Oxford Levels of Evidence 2: Oxford Centre for Evidence-Based Medicine. 2011 http:\/\/www.cebm.net\/index.aspx?o=5653 (accessed 26 October 2017)."},{"key":"2025121511151943000_8.6.e021064.25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12874-017-0325-5","article-title":"Evaluation of AMSTAR to assess the methodological quality of systematic reviews in overviews of reviews of healthcare interventions","volume":"17","author":"Pollock","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"2025121511151943000_8.6.e021064.26","doi-asserted-by":"publisher","DOI":"10.1111\/1468-0009.12210"},{"key":"2025121511151943000_8.6.e021064.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2014.08.008"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-021064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:15:27Z","timestamp":1765826127000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-021064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,27]]},"published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1136\/bmjopen-2017-021064"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-021064","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}